This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Theophylline

Authoring team

Theophylline is used in the treatment of bronchospasm - ie in reversible airways obstruction and severe asthma. It is a bronchodilator available in modified release preparations which are able to provide therapeutic plasma concentrations for 12 hours.

There is a narrow margin between the therapeutic and toxic doses, and the half life can be modified by a variety of factors, making a therapeutic dose hard to achieve.

Factor which increase the half life include heart failure, cirrhosis, viral infection and drugs like cimetidine, ciprofloxacin, erythromycin and the oral contraceptive pill.

The half life is decreased by smoking, heavy drinking and drugs like phenytoin, carbamazepine, rifampicin and barbiturates.

Note that, unlike many other drugs, the proprietry brand of theophylline strongly influences the pharmacodynamics. Thus theophylline should be prescribed by brand name as well as generic name.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.